47
Views
5
CrossRef citations to date
0
Altmetric
Original

Identification of Nck Interacting Proteins in Vascular Smooth Muscle Cells

, M.D., , Ph.D., , , M.D. & , M.D.
Pages 267-275 | Received 11 Mar 2002, Accepted 04 Oct 2002, Published online: 26 Apr 2004
 

Abstract

The adaptor molecule Nck has been demonstrated to mediate Angiotensin II (AngII)‐induced stimulation of p21‐activated kinase (PAK) and c‐Jun NH2‐terminal kinase (JNK) in vascular smooth muscle cells (VSMC). We have previously demonstrated, that immunoprecipitation of Nck from VSMC stimulated by AngII yielded an unidentified 100 kD phosphotyrosine (pTyr) protein. The present study was aimed at identifying the Nck‐associated 100 kD pTyr protein in VSMC. Several candidate proteins of appropriate size, that had been shown previously either to bind to Nck or had been implicated in signal transduction pathways leading to activation of PAK or JNK were tested for association with Nck in VSMC. The first candidate protein we tested was Git1, which did not bind to Nck in VSMC upon stimulation by AngII. However, we identified dynamin as a 100 kD protein that was bound to Nck in VSCM via interaction with the third Nck–SH3 domain. However, dynamin was not tyrosine phosphorylated by AngII treatment and seemed to be distinct from the 100 kD phosphotyrosine protein that was found in Nck immunoprecipitates. Future work will now have to identify the Nck‐associated 100 kD pTyr protein and functional studies will have to address its role in AngII signaling.

Abbreviations
AngII:=

angiotensin II

AT1R:=

angiotensin type 1 receptor

EGF:=

epidermal growth factor

ERK1/2:=

extracellular signal‐regulated kinase

GST:=

glutathione‐S transferase

JNK:=

c‐Jun NH2‐terminal kinase

LPA:=

lysophosphatidic acid

MAP kinase:=

mitogen activated protein kinase

PAK:=

p21‐activated kinase

PCR:=

polymerase chain reaction

SH domain:=

src homology domain

VSMC:=

vascular smooth muscle cells

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.